News
3d
MedPage Today on MSNNovel Lupus Drug Clears Phase II HurdleCalled enpatoran, the agent targets the Toll-like receptor (TLR) species 7 and 8. Some 50%-60% of patients with systemic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results